Full Text
Budget Impact Analysis for Daclizumab Beta In Relapsing Remitting Multiple Sclerosis In Italy

Abstract

Authors

F Demma G Casamassima E Cocco R Di Turi D Paolicelli S Fantaccini L Santoni G Furneri

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×